Where does Genethon rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genethon ranks #6,439 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genethon hold?

Genethon holds 52 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Genethon's Innovation Score?

Genethon has an Innovation Score of 44.2 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Genethon's patent grant rate increasing or decreasing?

Genethon's recent grant velocity is +27% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Genethon's patents?

Genethon's patents average 14.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genethon patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Genethon

Q: What technology areas does Genethon focus on?

Genethon's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 46 patents, ranking #220 of 4,144 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 52 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genethon ranks #6,439 of 49,997 tracked US assignees by granted-patent volume, with 52 patents across 12 technology areas.

#6,439
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.2/100): 14.5
avg claims per patent: +27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6439 · Foreign Corporation #6,439 · 52 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 52 grants
UPPER-Q #6,439/49,997
PHOTO-FINISH Equistar Chemicals
CPC-FOCUS C12N · 12 areas
INNOV-PAR 44.2/100
CLAIMS-RICH 14.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Equistar Chemicals, LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Genethon’s 44.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.7 pts (31%) Velocity 9.5 pts (22%) Breadth 12.2 pts (28%) Claim depth 8.7 pts (20%)

Qualcomm Incorporated · highest

85
Agenus · near

44
BeiGene · near

44
Genethon · this assignee

44
MTS Systems · near

44
Sequenom · near

44
3D Lighting… · lowest

7

What this shows Genethon's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Genethon?

Each dot is one of Genethon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genethon’s own 14.5 claims/patent is at or below the 16.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Genethon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Genethon's grants concentrate

Genethon is a focused PatentsView assignee: 12 CPC subclasses with 88.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2022 (10 grants) versus a trough of 2 in 2017. By volume, Genethon sits between Equistar Chemicals, LP and HUBER+SUHNER AG.

Genethon's three-year grant acceleration

Genethon shows 20 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Equistar Chemicals

52
Federated Wireless

52
Formfactor

52
Freedman Pty

52
Gamesys

52
Gaming Arts

52
HRB Innovations

52
Huber+Suhner

52
Genethon ◀

52

What this shows Genethon holds 52 patents at rank #6,437, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genethon

By rank, the assignees closest to #6,437 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Genethon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Genethon, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Genethon ranks #220 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Agenus Inc. 44 BeiGene, Ltd. 44 MTS Systems Corporation 44 Sequenom, Inc. 44

Similar claim depth

Nearest assignees by average claims per patent (14.5 here).

Ansaldo Energia IP UK Limited 14.5 avg The Hospital for Sick Children 14.5 avg Johnson & Johnson Surgical Vision, Inc. 14.5 avg BYD Company Limited 14.5 avg

Genethon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Genethon patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	7.7%
2016	3	5.8%
2017	2	3.8%
2018	7	13.5%
2019	6	11.5%
2020	6	11.5%
2021	2	3.8%
2022	10	19.2%
2023	5	9.6%
2024	5	9.6%
2025partial year	2	3.8%

Which technologies does Genethon patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 46

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 38

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 32

C12Y - Enzymes 15

C07K - Peptides 11

Y02A - Technologies FOR Adaptation TO Climate Change 5

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Genethon's patent record in context - here's where to go next.

Genethon's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 88.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #6,439 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Genethon against Equistar Chemicals, LP, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.